What is the Australian Clinical Labs (ASX: ACL) share price?
The ACL share price is $2.21, up 0.91% for the day, based on the latest available ASX market data.
What is Australian Clinical Labs's market capitalisation?
Australian Clinical Labs has a market capitalisation of $412.2M, making it the 501st-largest security listed on the ASX.
Does Australian Clinical Labs pay a dividend?
Yes. ACL has a trailing dividend yield of 3.29%.
What is ACL's P/E ratio?
Australian Clinical Labs trades on a trailing price-to-earnings (P/E) ratio of 23.92, based on its current share price and most recent reported earnings.
Is Australian Clinical Labs profitable?
Yes. In its most recent reported period (ending 31 Dec 2025), ACL reported revenue of $361.4M and a net profit of $5.6M.
How many ACL shares are on issue?
Australian Clinical Labs has approximately 186,518,985 shares on issue, based on its market capitalisation of $412.2M and current share price.
What sector is Australian Clinical Labs in?
Australian Clinical Labs is classified in the Healthcare sector, within the Medical - Diagnostics & Research industry on the ASX.
When did Australian Clinical Labs list on the ASX?
Australian Clinical Labs listed on the Australian Securities Exchange on 14 May 2021.
